An anal sex specific prototype of a new generation of condoms is being tested by Boston’s Fenway Institute as part of a clinical trial by the US National Institutes of Health.
Origami Condoms have developed a new kind of sexual barriers which simulate condomless sex and their anal condom hopes to be a game changer in preventing the spread of sexually transmitted infections among gay men.
Insertive condoms for women have been available in the past but the Origami Anal Condom is the first condom designed for use by a passive partner during anal sex.
The US Food and Drug Administration has never approved a condom specifically designed for use in anal sex and the National Institutes of Health wants to change that.
Origami condoms have also developed new insertive condoms for women and a penile condom for men.
The condoms are made from allergy free silicone and are designed to give greater stimulation to both partners’ genitals simultaneously during sex.
Origami hopes to conduct large scale clinical trials in 2014 to prepare for the condoms reaching the market for a 2015 target date.
For information about participating in the Fenway Institute trial contact Jake Tinsley at 617-927-6450 or email firstname.lastname@example.org